Proposed Collection; 60-Day Comment Request: National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer Platform Partnership Scientific Progress Reports, 27974-27975 [2013-11294]
Download as PDF
<![CDATA[
27974
Federal Register / Vol. 78, No. 92 / Monday, May 13, 2013 / Notices
of HHS to establish a public education
program to increase awareness about
organ donation and the need to provide
for an adequate rate of such donations.
In brief, DoT’s responsibilities are twofold: (1) To provide oversight and
guidance to the national organ
transplant system in the U.S. including
monitoring the Organ Procurement and
Transplantation Network and the
Scientific Registry of Transplant
Recipients; and (2) to implement a
program of public and professional
education and outreach aimed at
increasing the number of organ donors
in this country. Many preventable
deaths occur each year because of a
staggering imbalance between the
supply and demand for donor organs.
As of March 2013, the national
transplant waiting list exceeded
117,000. In 2011, the total number of
deceased and living organ donors was
only 14,145. These donors enabled
28,538 patients to receive a transplant
while 6,693 died waiting. Without
successful interventions to increase
donation, the disparity between need
and supply is likely to be substantially
exacerbated, resulting in more
unnecessary deaths.
Organdonor.gov is DoT’s primary
mechanism for providing the public
with information about organ donation.
Among the most visited pages on
organdonor.gov are the donor and
recipient life stories which in a recent
evaluation study were shown to raise
interest on the topic and, more
important, persuade people to register
as organ donors. To expand this
component of organdonor.gov, DoT
proposes to develop an application to
give organ recipients, living donors, and
donor families the opportunity to
voluntarily submit their stories to DoT
via a standardized online form. The
online form will be posted on
organdonor.gov and will collect
demographic and contact information,
the individual’s donation/transplant
story up to 500 words, a high resolution
photo, and a signed authorization. The
standardized, electronic form will
increase HRSA staff’s ability to process
those stories more efficiently. In
addition to enabling story submission,
the online application process will
make the donor and recipient life stories
posted on the site searchable by the
Number of
respondents
Form name
Responses per
respondent
public to enhance public viewing and
understanding of the organ donation
process. Submission of a story and
completion of the form is voluntary.
Overall, this application has the
potential to strengthen DoT’s outreach
efforts and increase organ donation
registration in the United States.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total
burden hours
Donation/Transplantation Life Story Submission Form .....
100
1
100
0.68
68
Total ............................................................................
100
1
100
0.68
68
Submit your comments to
the desk officer for HRSA, either by
email to
OIRA_submission@omb.eop.gov or by
fax to 202–395–5806. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Deadline: Comments on this ICR
should be received within 30 days of
this notice.
ADDRESSES:
Dated: May 7, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–11257 Filed 5–10–13; 8:45 am]
BILLING CODE 4165–15–P
tkelley on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dates and Times: May 21, 2013, 8:30
a.m. to 5:00 p.m., May 22, 2013, 8:00
a.m. to 12:00 p.m.
Status: The meeting of the National
Advisory Council on Migrant Health,
scheduled for May 21 and 22, 2013, is
cancelled. This cancellation applies to
all sessions of the meeting. The meeting
was announced in the Federal Register
of April 17, 2013 (78 FR 22890).
FOR FURTHER INFORMATION CONTACT:
Gladys Cate, Public Health Analyst,
Office of National Assistance and
Special Populations, Bureau of Primary
Health Care, Health Resources and
Services Administration, 5600 Fishers
Lane, Room 15–74, Rockville, Maryland
20857; telephone (301) 594–0367.
Dated: May 7, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
Health Resources and Services
Administration
National Advisory Council on Migrant
Health; Cancellation of Meeting
[FR Doc. 2013–11259 Filed 5–10–13; 8:45 am]
BILLING CODE 4165–15–P
Name: National Advisory Council on
Migrant Health.
VerDate Mar<15>2010
16:13 May 10, 2013
Jkt 229001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request: National Cancer Institute
(NCI) Alliance for Nanotechnology in
Cancer Platform Partnership Scientific
Progress Reports
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
E:\FR\FM\13MYN1.SGM
13MYN1
27975
Federal Register / Vol. 78, No. 92 / Monday, May 13, 2013 / Notices
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dorothy Farrell, Center
for Strategic Scientific Initiatives, Office
of Cancer Nanotechnology Research,
National Cancer Institute, 31 Center
Drive, Bldg. 31 A, Rm. 10A52, Bethesda,
MD 20892 or call non-toll-free number
301–496–5652 or Email your request,
including your address to:
farrelld@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: National Cancer
Institute (NCI) Alliance for
Nanotechnology in Cancer Platform
Partnership Scientific Progress Reports,
0925–NEW, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: National Institutes of Health
grantees are required to submit interim
and final progress reports and other
post-award documents associated with
the monitoring, oversight, and closeout
of an award. This submission represents
a request for OMB to approve new
program specific progress report
guidelines for Cancer Nanotechnology
Platform Partnerships (CNPP) awarded
by the National Cancer Institute (NCI).
The CNPPs are part of the Alliance for
Nanotechnology in Cancer, a network of
awards funded by NCI to promote the
application of nanotechnology to cancer
research and care. The proposed
guidelines request information about
award performance related to trans-
Alliance collaboration, scientific
milestones, progress towards clinical
translation and technology
commercialization, and education and
outreach efforts. The report also gathers
information on leveraged funding,
patents and publications. The
information is gathered every six
months. This information is needed to
monitor the performance of this special
program within NCI, funded through
Requests for Applications (RFA CA–09–
013, released May 29, 2009) using the
cooperative agreement mechanism
(U01). The information will be used to
monitor individual award performance
and the effectiveness of the program as
a whole. The respondents are the
Principal Investigators of the awards,
along with their institutional business
officials. The awards are administered
by and the reports reviewed by the
Office of Cancer Nanotechnology
Research (OCNR), part of the Center for
Strategic Scientific Initiatives within
NCI.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The estimated
annualized burden hours are 72.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Frequency of
response
Average time
per response
(in hours)
Annual burden
hours
Principal Investigators ......................................................................................
12
2
3
72
Dated: May 7, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, NCI, NIH.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2013–11294 Filed 5–10–13; 8:45 am]
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Endocrinology.
Date: June 3, 2013.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Krish Krishnan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, (301) 435–
1041, krishnak@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Hypertension and Microcirculation Study
Section.
Date: June 6, 2013.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW., Washington, DC
20036.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
Center for Scientific Review Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
VerDate Mar<15>2010
16:13 May 10, 2013
Jkt 229001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Transplantation,
Tolerance, and Tumor Immunology Study
Section.
Date: June 6–7, 2013.
Time: 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC
Downtown Hotel, 999 Ninth Street NW.,
Washington, DC 20001.
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4199,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Health
Services Organization and Delivery
Overflow.
Date: June 11, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 78, Number 92 (Monday, May 13, 2013)]
[Notices]
[Pages 27974-27975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11294]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request: National Cancer
Institute (NCI) Alliance for Nanotechnology in Cancer Platform
Partnership Scientific Progress Reports
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI), National Institutes of Health (NIH), will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have
[[Page 27975]]
practical utility; (2) The accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the information to be collected;
and (4) Ways to minimize the burden of the collection of information on
those who are to respond, including the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Dorothy
Farrell, Center for Strategic Scientific Initiatives, Office of Cancer
Nanotechnology Research, National Cancer Institute, 31 Center Drive,
Bldg. 31 A, Rm. 10A52, Bethesda, MD 20892 or call non-toll-free number
301-496-5652 or Email your request, including your address to:
farrelld@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: National Cancer Institute (NCI) Alliance for
Nanotechnology in Cancer Platform Partnership Scientific Progress
Reports, 0925-NEW, National Cancer Institute (NCI), National Institutes
of Health (NIH).
Need and Use of Information Collection: National Institutes of
Health grantees are required to submit interim and final progress
reports and other post-award documents associated with the monitoring,
oversight, and closeout of an award. This submission represents a
request for OMB to approve new program specific progress report
guidelines for Cancer Nanotechnology Platform Partnerships (CNPP)
awarded by the National Cancer Institute (NCI). The CNPPs are part of
the Alliance for Nanotechnology in Cancer, a network of awards funded
by NCI to promote the application of nanotechnology to cancer research
and care. The proposed guidelines request information about award
performance related to trans-Alliance collaboration, scientific
milestones, progress towards clinical translation and technology
commercialization, and education and outreach efforts. The report also
gathers information on leveraged funding, patents and publications. The
information is gathered every six months. This information is needed to
monitor the performance of this special program within NCI, funded
through Requests for Applications (RFA CA-09-013, released May 29,
2009) using the cooperative agreement mechanism (U01). The information
will be used to monitor individual award performance and the
effectiveness of the program as a whole. The respondents are the
Principal Investigators of the awards, along with their institutional
business officials. The awards are administered by and the reports
reviewed by the Office of Cancer Nanotechnology Research (OCNR), part
of the Center for Strategic Scientific Initiatives within NCI.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The estimated annualized burden
hours are 72.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Type of respondents Number of Frequency of per response Annual burden
respondents response (in hours) hours
----------------------------------------------------------------------------------------------------------------
Principal Investigators..................... 12 2 3 72
----------------------------------------------------------------------------------------------------------------
Dated: May 7, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, NCI, NIH.
[FR Doc. 2013-11294 Filed 5-10-13; 8:45 am]
BILLING CODE 4140-01-P
